This TSX Stock Stands to Benefit From the COVID-19 Pandemic

This TSX stock continues to benefit from the disruptions caused by the COVID-19 pandemic.

| More on:
Coronavirus written newspaper close up shot to the text.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The COVID-19 pandemic has dramatically changed the way we work and live, and this change is likely to be the new normal. As we battle the virus, we are transitioning to working from home, ordering things online, and avoiding unnecessary travel. Moreover, companies around the world are thinking of an operating model where the majority of their workforce will permanently work from home after the pandemic. 

Amid such a scenario, shares of companies providing products that support remote work should gain significantly. One such TSX stock is Enghouse Systems (TSX:ENGH). The company offers products and solutions that support remote work and visual computing. 

Investors should note that Enghouse is one of the few Canadian companies that is benefiting from the COVID-19 pandemic. The demand for its software and solutions are witnessing increased demand leading to the stellar growth in its revenues and profitability. 

Growth drivers  

Enghouse, through its IMG (Interactive Management Group) segment, offers customer interaction software and services that support remote work and helps in managing customer communications. The demand for its product and services is on the rise and will continue to increase in the coming quarters.

Enghouse continues to benefit from the sustained momentum in its base business. Meanwhile, acquisitions remain a large part of its strategy to diversify and accelerate growth. For instance, Enghouse’s recent acquisitions of Vidyo, Espial, and Dialogic have helped it to post stellar sales and earnings growth in the most recent quarter and support the expansion of its product suite.

Strong financials

Even before the pandemic-led demand, Enghouse has been performing exceptionally well. Enghouse’s revenues have increased at a CAGR of 8% since fiscal 2015. Meanwhile, its top-line growth rate has just started to accelerate, implying stellar revenues in the future. The strong revenues drove double-digit growth in its EBITDA, which has increased at a CAGR of 14% during the same period. 

Enghouse’s low dividend yield of 0.8% might not attract you. However, its dividends have grown at a CAGR of 16% since fiscal 2015. Moreover, the company’s stellar financial performance and steady growth in profitability indicate that the dividends are going to increase in the future. 

Investors should note that Enghouse’s revenues jumped 58% in the most recent quarter thanks to the 102% growth in its IMG segment. The IMG segment benefited from the continued strength in its base business and the addition of Vidyo and Dialogic.

Meanwhile, Enghouse’s Asset Management Group’s revenues also marked a double-digit growth during the last reported quarter, thanks to the acquisitions of Espial and Dialogic. 

Tremendous top-line growth drove an about 81% increase in its adjusted EBITDA. Meanwhile, adjusted EBITDA margin expanded by 450 basis points to 35%. Its net income jumped by 64% in the most recent quarter, reflecting a surge in revenues and EBITDA.

Bottom line

Enghouse stock has consistently outperformed the benchmark index by a considerable margin. Its stock is up about 41% so far this year, as compared to the 8% decline in the benchmark index. Further, Enghouse stock is up about 82% in one year compared to the 3% decline in the broader markets. Also, Enghouse stock has risen by more than 150% in five years, as compared to a paltry 7.6% rise in the benchmark index.

Enghouse stock could continue to surge higher from consistent demand for its products. Besides, its strong balance sheet with minimal debt positions it well to gain from future acquisitions.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool recommends Enghouse Systems Ltd.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »